Vinca alkaloids in the treatment of non-small cell lung cancer

A Southwest Oncology Group study

1993 • 778 citations

Prognostic Factors for Survival in Patients With Inoperable Lung Cancer<xref ref-type="fn" rid="FN2">2</xref>

1980 • 569 citations

Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules

1981 • 367 citations

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

1986 • 337 citations

The effect of measuring error on the results of therapeutic trials in advanced cancer

1976 • 255 citations

Results of surgical treatment in Stage I lung cancer

1977 • 165 citations

Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens.

1985 • 109 citations

Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study

1984 • 84 citations

Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.

1985 • 81 citations

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment

1985 • 77 citations

Vinblastine in Neoplastic Disease Midwest Cooperative Chemotherapy Group

1963 • 72 citations

COMB (cyclophosphamide, oncovin, methyl-ccnu, and bleomycin): A four-drug combination in solid tumors

1975 • 64 citations

Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.

1980 • 63 citations

Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine

1976 • 59 citations

Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer

1986 • 46 citations

Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.

1979 • 46 citations

New agents in non-small cell lung cancer

1984 • 44 citations

Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.

1983 • 32 citations

Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vincristine, and mitomycin C (FOMi).

1980 • 29 citations

Comparative trial of combination chemotherapy in extensive squamous carcinoma of the lung: a Southwest Oncology Group Study.

1977 • 27 citations

Trial of Vindesine plus Mitomycin in Stage-3 Non-small Cell Lung Cancer

1985 • 27 citations

Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer

1983 • 26 citations

cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.

1979 • 25 citations

Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancer.

1983 • 24 citations

Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.

1983 • 24 citations

Vindesine: an effective agent in the treatment of non-small cell lung cancer.

1982 • 24 citations

Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.

1982 • 23 citations

A controlled trial of vinblastine sulphate in the treatment of cancer of the lung

1966 • 22 citations

Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.

1982 • 21 citations

Phase ii evaluation of a combination of mitomycin C, vincristine, and cisplatin in advanced non-small cell lung cancer

1986 • 21 citations

Cis-platinum and vindesine in combination in the treatment of non-small cell lung cancer

1985 • 20 citations

Therapeutic efficacy and pharmacokinetics of vindesine and vindesine-cisplatin in previously treated patients with non-small cell lung carcinoma

1983 • 19 citations

Platinum-based combination chemotherapy in non-small cell lung carcinoma

1981 • 19 citations

Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results

1980 • 19 citations

Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma.

1982 • 18 citations

Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung

1986 • 18 citations

A randomized prospective study of vindesine versus doxorubicin and cyclophosphamide in the treatment of epidermoid lung cancer

1983 • 17 citations

Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.

1982 • 17 citations

ICRF-159 versus polychemotherapy in non-small cell lung cancer.

1976 • 16 citations

Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma.

1983 • 15 citations

Combined Chemotherapy for Squamous Cell Carcinoma of the Lung

1978 • 15 citations

Vindesine chemotherapy in lung cancer

1980 • 15 citations

Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).

1984 • 14 citations

Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.

1982 • 12 citations

An active chemotherapy regimen for squamous cell lung cancer.

1984 • 10 citations

Vindesine in the Treatment of Squamous Cell Carcinoma (Who I), Adenocarcinoma (Who III), and Large Cell Carcinoma (who IV) of the Lung

1982 • 10 citations

Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.

1983 • 10 citations

Oral vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon/rectum

1985 • 10 citations

New agents and combinations in the treatment of bronchogenic carcinoma.

1973 • 9 citations

Combination chemotherapy with bleomycin (NSC 125066), adriamycin (NSC 123127), CCNU (NSC 79037), vincristine (NSC 67574), and mechlorethamine (NSC 762) (BACON) in squamous cell lung cancer: experience with 50 patients

1975 • 9 citations

Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.

1976 • 9 citations

Salivary and urinary lithium clearance while recumbent and upright

1977 • 8 citations

Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.

1984 • 8 citations

Influence of measurement error on response rates.

1985 • 8 citations

Vindesine versus Vindesine with Cis-Platinum in Metastatic Non-Small Cell Lung Cancer

1981 • 7 citations

Phase II study of vindesine in patients with non-small cell lung cancer.

1985 • 7 citations

Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.

1985 • 6 citations

Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.

1976 • 6 citations

Clinical study of vincristine in adenocarcinoma of the lung

1980 • 6 citations

Continuous Vindesine Infusion Therapy in Cases of Advanced Non-Small Cell Bronchogenic Carcinoma

1981 • 6 citations

Chemotherapy of non‐small cell lung cancer: Clinical trials at the Memorial Sloan‐Kettering Cancer Center

1981 • 5 citations

The chemotherapy of advanced squamous cell carcinomas: Long term results obtained with a combination of methotrexate, the vinca alkaloids and bleomycin

1982 • 5 citations

Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: A southwest oncology group study

1986 • 5 citations

Phase II trial of vindesine in adenocarcinoma of the lung.

1984 • 5 citations

Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.

1984 • 5 citations

Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.

1983 • 4 citations

Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.

1985 • 4 citations

Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).

1982 • 4 citations

Methotrexate, Cyclophosphamide and Vindesine versus Methotrexate, Cyclophosphamide and Vinblastine in Advanced Lung Cancer1

1981 • 4 citations

Kombinationschemotherapie bei Patienten mit metastasiertem Bronchialcarcinom

1977 • 3 citations

Phase II trial of 5-FU, vincristine, and mitomycin (FoMi) in metastatic bronchioloalveolar cell lung cancer: A southwest oncology group study

1986 • 3 citations

Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.

1977 • 3 citations

Experience with the Combination of Cis-Platinum and Vindesine in the Treatment of Squamous Cell Carcinomas, Adenocarcinomas and Large Cell Bronchogenic Carcinomas

1981 • 3 citations

Cisplatin, Vindesin und VP 16–213 in der Behandlung des inoperablen nicht-kleinzelligen Bronchialkarzinoms

1984 • 2 citations

Chemotherapie des fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms mit Cisplatin und Vindesin

1984 • 2 citations

Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).

1983 • 2 citations

[Treatment of non-small-cell bronchial carcinoma with cisplatin, ifosfamide, vindesine and VP 16].

1985 • 2 citations

Phase II study of mitomycin, methotrexate, and vincristine combination chemotherapy in advanced adenocarcinoma of the lung.

1984 • 2 citations

Chemotherapy of Inoperable Non-small Cell Carcinoma of the Lung with Vindesine, Cis-Platinum and Cyclophosphamide

1981 • 2 citations

Doxorubicin, vincristine, bleomycin, cytembena and cisplatin as combination chemotherapy for squamous cell lung cancer.

1983 • 2 citations

Vindesine and high‐dose cisplatin in the treatment of advanced non‐small‐cell lung cancer

1985 • 1 citations

Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.

1983 • 1 citations

Non small cell lung cancer: A randomised comparison of chemotherapy with no chemotherapy

1986 • 1 citations

Deleted Work

1955 • 0 citations